$FEMY, might be worth keeping an eye on🚀
Femasys is quietly doing its thing, and it’s starting to catch my eye. They just got the CE Mark for FemBloc, the first non-surgical permanent birth control system approved in Europe, and early orders are already coming in from Spain. The rollout across other countries is on the horizon, and imo that alone is a pretty big deal.
On top of that, they’ve got FDA trials underway in the U.S. for some of their other women’s health devices, and the recent $8 million financing gives them the runway to actually get products out there and into more markets. Being added to the Russell Microcap Growth Index will also bring in some extra eyes and volume.
There’s a bunch of catalysts lined up: upcoming revenue updates, more European launches, and clinical readouts. For a microcap that’s flying a bit under the radar, it’s the kind of story that could quietly pop if everything clicks. Currently sitting at $0.48, but analysts have it averaging $5.67 👀. Just got in with a decent position, hoping next week brings more recognition!
What are your guys' thoughts?
Posted Oct 3, 2025, 5:06 PM UTC